Market Update: Gilead Sciences Inc (NASDAQ:GILD) – Gilead Sciences to Present at the Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 10

[Business Wire] – Gilead Sciences, Inc. today announced that its corporate presentation will be webcast from the Bank of America Merrill Lynch Healthcare Conference in Las Vegas. Read more on this. Gilead Sciences Inc. (GILD) , currently valued at $115.48B, opened at $84.99. During today’s session, GILD traded between $84.70 to $86.46 with the price of the stock fluctuating between $81.89 to $123.37 over the last 52 weeks. GILD shares are currently priced at 7.01x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -1.94x earnings multiple for the same period. And for income investors, the company pays shareholders $1.88 per share annually in dividends, yielding 2.22%. In a review of the consensus earnings estimate this quarter, 21 sell-side analysts are looking at $3.00 per share, which would be $0.15 worse than the year-ago quarter and a $0.05 sequential decrease. What we find to be interesting is that the full-year EPS estimate of $12.08 is a $0.53 worse when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $7.75 Billion. If realized, that would be a 5.95% decrease over the year-ago quarter. More recently, Maxim Group downgraded GILD from Buy to Hold (Apr 29, 2016). Previously, Citigroup Initiated GILD at to Buy. With the above information in mind, readers should note that the average price target is $111.29, which is 30.94% above where the stock opened this morning. See more in (NASDAQ:GILD) Similar Articles: Company Update (NASDAQ:GILD): Gilead Sciences to Present at the Cowen & Company 36th Annual Health Care Conference on Monday, March 7 Stock Update (NASDAQ:GILD): Gilead Sciences to Release Fourth Quarter and Full Year 2015 Financial Results on Tuesday, February 2, 2016 Company Update (NASDAQ:GILD): Gilead Sciences to Present at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11